Furthermore, biochemical abnormalities such as elevated estrogen bioactivity, reduced circulating adiponectin concentrations, and hyperinsulinemia, which have been identified as contributing factors in breast cancer pathogenesis and progression, occur in both type 2 diabetes and obesity. Here, ADIPOQ is linked to Hyperinsulinemia.